Work

Rapid Clinical Improvement With Tyrosine Kinase 2 Inhibitor Deucravacitinib in Overlapping Psoriasis and Atopic Dermatitis

Year: 2025
Type: article
Abstract: The authors declare no conflicts of interest. The data supporting this study's findings are available from the corresponding author upon reasonable request.
Language: English
Subfield: Immunology
Open Access status: bronze
OpenAlex ID: W4409568038
FWCI: 2.369
Cites: 8
Cited by: 8
Related to: 10